ClearTrial to Demonstrate Dramatic Gains in Clinical Outsourcing Efficiency
Achieved by Biopharmaceutical Companies at European Outsourcing Event
Software shortens contract closure time for one customer from 2 ½ months to 2 ½ weeks; saves
another customer 20% of outsourcing costs
London, United Kingdom (PRWEB) February 2, 2010 -- ClearTrial (www.cleartrial.com), the leading provider of
Clinical Trial Operations (CTO) software, today announced that it will be demonstrating the software's
capabilities to drive greater outsourcing efficiency to an audience of more than 125 clinical outsourcing
professionals at the 3rd Annual Clinical Outsourcing World conference in London. The event attracts
biopharmaceutical companies from around the globe to hear top clinical outsourcing experts discuss major
strategic and operational challenges of partnering with clinical research organizations (CROs).
Attendees of the conference will discover firsthand how ClearTrial software is helping biopharmaceutical
companies worldwide gain speed and consistency and cut costs in the outsourcing function:
• Rapid "what-if" scenarios to choose the best outsourcing model for studies
• Accurate cost comparisons between types of CROs
• Fast, consistent RFP development
• Streamlined contract negotiations
• Greater visibility to cost and resource requirements, both internal and outsourced
• Minimized change orders and their corresponding impact on the organization
ClearTrial software is built on an activity-based or “project management” architecture, which enables the
software to provide greater speed, accuracy, and flexibility to outsourcing groups and clinical operations.
Supporting all outsourcing models and contract types, as well as 39 currencies and over 150 therapeutic
indications, the software automatically calculates labor costs across 70 different countries.
Cubist Pharmaceuticals, Inc., a Massachusetts-based biopharmaceutical company focused on the research,
development, and commercialization of pharmaceutical produc